Austin JW - Search Results

1

Individual characteristics and management decisions affect outcome of anticoagulated patients with intracranial hemorrhage.

Hawryluk GW, Furlan JC, Austin JW, Fehlings MG. Hawryluk GW, et al. Among authors: austin jw. World Neurosurg. 2014 May-Jun;81(5-6):742-51. doi: 10.1016/j.wneu.2013.01.080. Epub 2013 Jan 19. World Neurosurg. 2014. PMID: 23336984 Review.

2

Spinal haemorrhage during anticoagulant regimen for thromboprophylaxis: a unique form of central nervous system haemorrhage.

Furlan JC, Hawryluk GW, Austin J, Fehlings MG. Furlan JC, et al. J Neurol Neurosurg Psychiatry. 2012 Jul;83(7):746-52. doi: 10.1136/jnnp-2011-301366. Epub 2012 May 7. J Neurol Neurosurg Psychiatry. 2012. PMID: 22566595

3

Management of anticoagulation following central nervous system hemorrhage in patients with high thromboembolic risk.

Hawryluk GW, Austin JW, Furlan JC, Lee JB, O'Kelly C, Fehlings MG. Hawryluk GW, et al. Among authors: austin jw. J Thromb Haemost. 2010 Jul;8(7):1500-8. doi: 10.1111/j.1538-7836.2010.03882.x. Epub 2010 Apr 8. J Thromb Haemost. 2010. PMID: 20403088 Free article.

4

Survey of neurosurgical management of central nervous system hemorrhage in patients receiving anticoagulation therapy: current practice is highly variable and may be suboptimal.

Hawryluk GW, Furlan JC, Austin JW, Fehlings MG. Hawryluk GW, et al. Among authors: austin jw. World Neurosurg. 2011 Sep-Oct;76(3-4):299-303. doi: 10.1016/j.wneu.2011.03.034. World Neurosurg. 2011. PMID: 21986428

5

Molecular mechanisms of Fas-mediated cell death in oligodendrocytes.

Austin JW, Fehlings MG. Austin JW, et al. J Neurotrauma. 2008 May;25(5):411-26. doi: 10.1089/neu.2007.0436. J Neurotrauma. 2008. PMID: 18435595

6

High molecular weight hyaluronan reduces lipopolysaccharide mediated microglial activation.

Austin JW, Gilchrist C, Fehlings MG. Austin JW, et al. J Neurochem. 2012 Jul;122(2):344-55. doi: 10.1111/j.1471-4159.2012.07789.x. Epub 2012 Jun 1. J Neurochem. 2012. PMID: 22587438 Free article.

7

The relationship between localized subarachnoid inflammation and parenchymal pathophysiology after spinal cord injury.

Austin JW, Afshar M, Fehlings MG. Austin JW, et al. J Neurotrauma. 2012 Jul 1;29(10):1838-49. doi: 10.1089/neu.2012.2354. J Neurotrauma. 2012. PMID: 22655536 Free PMC article.

8

Immunoglobulin G (IgG) attenuates neuroinflammation and improves neurobehavioral recovery after cervical spinal cord injury.

Nguyen DH, Cho N, Satkunendrarajah K, Austin JW, Wang J, Fehlings MG. Nguyen DH, et al. Among authors: austin jw. J Neuroinflammation. 2012 Sep 21;9:224. doi: 10.1186/1742-2094-9-224. J Neuroinflammation. 2012. PMID: 22998664 Free PMC article.

9

Riluzole attenuates neuropathic pain and enhances functional recovery in a rodent model of cervical spondylotic myelopathy.

Moon ES, Karadimas SK, Yu WR, Austin JW, Fehlings MG. Moon ES, et al. Among authors: austin jw. Neurobiol Dis. 2014 Feb;62:394-406. doi: 10.1016/j.nbd.2013.10.020. Epub 2013 Oct 29. Neurobiol Dis. 2014. PMID: 24184328

10

The effects of intrathecal injection of a hyaluronan-based hydrogel on inflammation, scarring and neurobehavioural outcomes in a rat model of severe spinal cord injury associated with arachnoiditis.

Austin JW, Kang CE, Baumann MD, DiDiodato L, Satkunendrarajah K, Wilson JR, Stanisz GJ, Shoichet MS, Fehlings MG. Austin JW, et al. Biomaterials. 2012 Jun;33(18):4555-64. doi: 10.1016/j.biomaterials.2012.03.022. Epub 2012 Mar 27. Biomaterials. 2012. PMID: 22459192

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters